Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Vaccine Treatment
Total 0 results
Nothing found
Sponsors and Collaborators
Cogniciti
UNITI Consortium
NERv Technology Inc
The Affiliated Hospital of Xuzhou Medical University
Huisartspraktijk Handellaan
Université de Genève (UNIGE)
BioNova Pharmaceuticals (Shanghai) LTD.
Health Information Technology Solutions (HITS) LLC
Salena Killion
Shanghai GeneChem Co., Ltd.
Smart Meter Corporation
Pia Jaeger, MD, PhD
Impulse Dynamics, Inc.
Zhongda Hospital, Medical School, Southeast University
Vivid Pharma Inc.
Nutrabolt
Hungarian Dental Association
HBSA
Defence Services Medical Academy (DSMA), Myanmar
Ministry of Public Health, Cameroon
View Full List
Medical Conditions
PET-CT Specimen Imager
PPA Syndrome
Radiofrequency Ablation Treatment
Biomarkers, Pharmacological
Pain, Breakthrough
Failed Induction
Cerebral Arterial Disease
Immediate Implant Placement
SMA - Spinal Muscular Atrophy
Infection, Bacterial
Research Mentoring Skills
VEXAS Syndrome
Old Age (Focus; Not a Recognized Condition)
Endoleaks
Advanced Bladder Carcinoma
Vertebral Compression Fractures in Osteoporotic Patients
Cardiovascular Primary Prevention
Alzheimer Disease Focal
Eye Disease, Hereditary
Premature Rupture of Membranes Prolonged
View Full List
Drug Interventions
TQB2450
Lacosamide
Rosuvastatin
Cefadroxil until drain removal
5 FU continuous
Phase B: Triplixam / Elestar HCT
Olopatadine hydrochloride 0.2%
18F-FDG
OXP005
INT-747
CNTO 6785 50 mg
Microneedling with topical glycolic acid 35%.
Durvalumab + chemotherapy treatment
Oxymorphone hydrochloride (HCl)
CJ-12420 200mg + Clarithromycin 500mg
80% oxygen
Acetylsalicylic acid
20 mg/kg IV FL-301
HPN328
0.75% Ropivacaine
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Brazil
Contract Research Organizations in China
Contract Research Organizations in Colombia
Contract Research Organizations in El Salvador
Contract Research Organizations in Estonia
Contract Research Organizations in Guinea
Contract Research Organizations in New Zealand
Contract Research Organizations in Oman
Contract Research Organizations in Poland
Contract Research Organizations in Romania
Contract Research Organizations in Uganda
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in New Zealand
P3 Research
GreenLight Clinical
PPD
Premier Research
Fortrea
SGS
Novotech
ICON
IQVIA
All CROs in New Zealand
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe